Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies

K Sumaiya, D Langford, K Natarajaseenivasan… - Pharmacology & …, 2022 - Elsevier
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine encoded within a
functionally polymorphic genetic locus. MIF was initially recognized as a cytokine generated …

The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies

SK Daniel, YD Seo, VG Pillarisetty - Seminars in cancer biology, 2020 - Elsevier
Single agent checkpoint inhibitor therapy has not been effective for most gastrointestinal
solid tumors, but combination therapy with drugs targeting additional immunosuppressive …

GPCRs: Emerging anti-cancer drug targets

AN Gutierrez, PH McDonald - Cellular signalling, 2018 - Elsevier
G protein-coupled receptors (GPCRs) constitute the largest and most diverse protein family
in the human genome with over 800 members identified to date. They play critical roles in …

Opportunities for therapeutic antibodies directed at G-protein-coupled receptors

CJ Hutchings, M Koglin, WC Olson… - Nature reviews Drug …, 2017 - nature.com
G-protein-coupled receptors (GPCRs) are activated by a diverse range of ligands, from large
proteins and proteases to small peptides, metabolites, neurotransmitters and ions. They are …

CXCR4 in Waldenström's Macroglobulinema: chances and challenges

LM Kaiser, ZR Hunter, SP Treon, C Buske - Leukemia, 2021 - nature.com
It is one of the major aims in cancer research to improve our understanding of the underlying
mechanisms which initiate and maintain tumor growth and to translate these findings into …

Targeting CXCR4 in AML and all

D Cancilla, MP Rettig, JF DiPersio - Frontiers in oncology, 2020 - frontiersin.org
The interaction of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as …

Potential role of CXCR4 targeting in the context of radiotherapy and immunotherapy of cancer

F Eckert, K Schilbach, L Klumpp, L Bardoscia… - Frontiers in …, 2018 - frontiersin.org
Cancer immunotherapy has been established as standard of care in different tumor entities.
After the first reports on synergistic effects with radiotherapy and the induction of abscopal …

Recent advances in CXCL12/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy

R Zhao, J Liu, Z Li, W Zhang, F Wang, B Zhang - Pharmaceutics, 2022 - mdpi.com
Chemokines can induce chemotactic cell migration by interacting with G protein-coupled
receptors to play a significant regulatory role in the development of cancer. CXC chemokine …

The CXCL12/CXCR4/ACKR3 axis in the tumor microenvironment: signaling, crosstalk, and therapeutic targeting

MJ Smit, G Schlecht-Louf, M Neves… - Annual review of …, 2021 - annualreviews.org
Elevated expression of the chemokine receptors CXCR4 and ACKR3 and of their cognate
ligand CXCL12 is detected in a wide range of tumors and the tumor microenvironment …

Structure, function and drug discovery of GPCR signaling

L Cheng, F Xia, Z Li, C Shen, Z Yang, H Hou… - Molecular …, 2023 - Springer
G protein-coupled receptors (GPCRs) are versatile and vital proteins involved in a wide
array of physiological processes and responses, such as sensory perception (eg, vision …